Immune to Cancer: The CRI Blog
-
Challenge Yourself to Write by Hand in 2021
National Handwriting Day is Saturday, January 23, 2021. Challenge yourself in 2021 with our '21 Challenge to…
-
Dr. Terence Friedlander Answers Questions on Bladder Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit
Terence Friedlander, MD, answers questions about immunotherapy for bladder cancer from the 2020 CRI Virtual Immunotherapy Patient…
-
Dr. Elizabeth M. Jaffee Answers Questions on Pancreatic Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit
Dr. Elizabeth Jaffee answers questions on immunotherapy for pancreatic cancer from the 2020 CRI Virtual Immunotherapy Patient…
-
Kidney Cancer and Immunotherapy with Dr. Saby George at the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Saby George discusses the latest updates in immunotherapy for kidney cancer at the 2020 CRI Virtual…
-
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz at the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Scott Kopetz discusses new advances and promising research in immunotherapy for colorectal cancer patients.
-
CRI-Funded Trial Highlights New Hope Against Pancreatic Cancer
New publication from the CRI PRINCE trial highlights benefits of an immunotherapy-chemotherapy combination against advanced pancreatic cancer.
-
Cervical Cancer Awareness Month: 2021 Immunotherapy Research Updates
This January for Cervical Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
CRI ImmunoAdvocate Perspective: Lung Cancer Survivor Oswald Shares His Immunotherapy Experience
CRI ImmunoAdvocate Oswald Peterson discusses his experience receiving a PD-1 checkpoint inhibitor for stage 4 non-small cell…
-
Dr. Kunle Odunsi Answers Questions About Ovarian Cancer and Immunotherapy From the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi of Roswell Park Comprehensive Cancer Center answers questions about ovarian cancer and immunotherapy from…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.